CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of ABT-888 in Combination With Cisplatin and Vinorelbine for Patients With Advanced Triple Negative Breast Cancer and/or BRCA-Mutation Associated Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01104259
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:28.394137+00:00
Published At: 2017-08-10T00:00:00+00:00
Record Updated At: 2017-08-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Estrogen Receptor-negative Breast Cancer", "HER2-negative Breast Cancer", "Hereditary Breast/Ovarian Cancer - BRCA1", "Hereditary Breast/Ovarian Cancer - BRCA2", "Male Breast Cancer", "Progesterone Receptor-negative Breast Cancer", "Recurrent Breast Cancer", "Stage IV Breast Cancer", "Triple-negative Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-08-10"
protocolSection.identificationModule.nctId: "NCT01104259"
protocolSection.identificationModule.officialTitle: "Phase I Study of ABT-888 in Combination With Cisplatin and Vinorelbine for Patients With Advanced Triple Negative Breast Cancer and/or BRCA-Mutation Associated Breast Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.